GenieBiome Ltd. has been approved for the admission into the the HKSTP-KingMed Co-Incubation Scheme ("Scheme") today. The Scheme is a 4-year program provided by Hong Kong Science and Technology Parks Corporation (HKSTPC), which aims to support the growth and development of biomedical tech start-ups in Hong Kong. Under this scheme, GenieBiome Ltd will work with HKSTPC and Guangzhou KingMed Diagnostics Group Co., Ltd. to bring innovative diagnostic and therapeutic solution to our next generation.
Admission into the HKSTP-KINGMED CO-INCUBATION SCHEME
Updated: May 4, 2022